-
1
-
-
0029900157
-
H-cadherin a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer
-
Lee, S.W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996, 2, 776-782.
-
(1996)
Nat Med
, vol.2
, pp. 776-782
-
-
Lee, S.W.1
-
2
-
-
0031683862
-
The Hcadherin (CDH13) gene is inactivated in human lung cancer
-
[Published erratum in Hum Genet 1998, 103 532]
-
Sato, M.; Mori, Y.; Sakurada, A.; Fujimura, S.; Horii, A. The Hcadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 1998, 103, 96-101. [Published erratum in Hum Genet 1998, 103, 532]
-
(1998)
Hum Genet
, vol.103
, pp. 96-101
-
-
Sato, M.1
Mori, Y.2
Sakurada, A.3
Fujimura, S.4
Horii, A.5
-
3
-
-
0035360824
-
Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas
-
Toyooka, K.O.; Toyooka, S.; Virmani, A.K.; Sathyanarayana, U.G.; Euhus, D.M.; Gilcrease, M.; Minna, J.D.; Gazdar, A.F. Loss of expression and aberrant methylation of the CDH13 (H-Cadherin) gene in breast and lung carcinomas. Cancer Res 2001, 61, 4556-4560. (Pubitemid 32685789)
-
(2001)
Cancer Research
, vol.61
, Issue.11
, pp. 4556-4560
-
-
Toyooka, K.O.1
Toyooka, S.2
Virmani, A.K.3
Sathyanarayana, U.G.4
Euhus, D.M.5
Gilcrease, M.6
Minna, J.D.7
Gazdar, A.F.8
-
4
-
-
0037096946
-
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas
-
Toyooka, S.; Toyooka, K.O.; Harada, K.; Miyajima, K.; Makarla, P.; Sathyanarayana, U.G.; Yin, J.; Sato, F.; Shivapurkar, N.; Meltzer, S.; Gazdar, A.F. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 2002, 62, 3382-3386.
-
(2002)
Cancer Res
, vol.62
, pp. 3382-3386
-
-
Toyooka, S.1
Toyooka, K.O.2
Harada, K.3
Miyajima, K.4
Makarla, P.5
Sathyanarayana, U.G.6
Yin, J.7
Sato, F.8
Shivapurkar, N.9
Meltzer, S.10
Gazdar, A.F.11
-
5
-
-
0036677245
-
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
-
Takeuchi, T.; Liang, S.B.; Matsuyoshi, N.; Zhou, S.; Miyachi, Y.; Sonobe, H.; Ohtsuki, Y. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 2002, 82, 1023-1029.
-
(2002)
Lab Invest
, vol.82
, pp. 1023-1029
-
-
Takeuchi, T.1
Liang, S.B.2
Matsuyoshi, N.3
Zhou, S.4
Miyachi, Y.5
Sonobe, H.6
Ohtsuki, Y.7
-
6
-
-
0036924686
-
Down-regulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin
-
Takeuchi, T.; Liang, S.B.; Ohtsuki, Y. Down-regulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinog 2002, 35, 173-179.
-
(2002)
Mol Carcinog
, vol.35
, pp. 173-179
-
-
Takeuchi, T.1
Liang, S.B.2
Ohtsuki, Y.3
-
7
-
-
4143090637
-
Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer
-
Sakai, M.; Hibi, K.; Koshikawa, K.; Inoue, S.; Takeda, S.; Kaneko, T.; Nakao, A. Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer. Cancer Sci 2004, 95, 588-591.
-
(2004)
Cancer Sci
, vol.95
, pp. 588-591
-
-
Sakai, M.1
Hibi, K.2
Koshikawa, K.3
Inoue, S.4
Takeda, S.5
Kaneko, T.6
Nakao, A.7
-
8
-
-
0031901799
-
H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo
-
Lee, S.W.; Reimer, C.L.; Campbell, D.B.; Cheresh, P.; Duda, R.B.; Kocher, O. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 1998, 19, 1157-1159.
-
(1998)
Carcinogenesis
, vol.19
, pp. 1157-1159
-
-
Lee, S.W.1
Reimer, C.L.2
Campbell, D.B.3
Cheresh, P.4
Duda, R.B.5
Kocher, O.6
-
9
-
-
0026052670
-
T-cadherin a novel cadherin cell adhesion molecule in the nervous system, lacks the conserved cytoplasmic region
-
Ranscht, B.; Dours-Zimmermann, M.T. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system, lacks the conserved cytoplasmic region. Neuron 1991, 7, 391-402.
-
(1991)
Neuron
, vol.7
, pp. 391-402
-
-
Ranscht, B.1
Dours-Zimmermann, M.T.2
-
10
-
-
1842390685
-
Cell binding function of E-cadherin is regulated by the cytoplasmic domain
-
Nagafuchi, A.; Takeichi, M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988, 7, 3679-3684.
-
(1988)
EMBO J
, vol.7
, pp. 3679-3684
-
-
Nagafuchi, A.1
Takeichi, M.2
-
11
-
-
53149102075
-
Insights into the low adhesive capacity of human T-cadherin from the NMR structure of its N-terminal extracellular domain
-
Dames, S.A.; Bang, E.; Haüssinger, D.; Ahrens, T.; Engel, J.; Grzesiek, S. Insights into the low adhesive capacity of human T-cadherin from the NMR structure of its N-terminal extracellular domain. J Biol Chem 2008, 283, 23485-23495.
-
(2008)
J Biol Chem
, vol.283
, pp. 23485-23495
-
-
Dames, S.A.1
Bang, E.2
Haüssinger, D.3
Ahrens, T.4
Engel, J.5
Grzesiek, S.6
-
12
-
-
0034066303
-
Expression of T-cadherin (CDH13, Hcadherin) in human brain and its characteristics as a negative growth regulator of EGF in neuroblastoma cells
-
Takeuchi, T.; Misaki, A.; Liang, S.B.; Tachibana, A.; Hayashi, N.; Sonobe, H.; Ohtsuki, Y. Expression of T-cadherin (CDH13, Hcadherin) in human brain and its characteristics as a negative growth regulator of EGF in neuroblastoma cells. J Neurochem 2000, 74, 1489-1497.
-
(2000)
J Neurochem
, vol.74
, pp. 1489-1497
-
-
Takeuchi, T.1
Misaki, A.2
Liang, S.B.3
Tachibana, A.4
Hayashi, N.5
Sonobe, H.6
Ohtsuki, Y.7
-
13
-
-
0037159513
-
IKKbeta, and NEMO/IKKgamma are each required for theNF-kappa B-mediated inflammatory response program
-
Li, X.; Massa, P.E.; Hanidu, A.; Peet, G.W.; Aro, P.; Savitt, A.; Mische, S.; Li, J.; Marcu, K.B. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for theNF-kappa B-mediated inflammatory response program. J Biol Chem 2002, 277, 45129-45140.
-
(2002)
J Biol Chem
, vol.277
, pp. 45129-45140
-
-
Li, X.1
Massa, P.E.2
Hanidu, A.3
Peet, G.W.4
Aro, P.5
Savitt, A.6
Mische, S.7
Li, J.8
Ikkalpha, B.M.K.9
-
14
-
-
0037220234
-
T-cadherinmediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression
-
Huang, Z.Y.; Wu, Y.; Hedrick, N.; Gutmann, D.H. T-cadherinmediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 2003, 23, 566-578.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 566-578
-
-
Huang, Z.Y.1
Wu, Y.2
Hedrick, N.3
Gutmann, D.H.4
-
15
-
-
4444362838
-
Tcadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells
-
Ivanov, D.; Philippova, M.; Allenspach, R.; Erne, P.; Resink, T. Tcadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 2004, 64, 132-143.
-
(2004)
Cardiovasc Res
, vol.64
, pp. 132-143
-
-
Ivanov, D.1
Philippova, M.2
Allenspach, R.3
Erne, P.4
Resink, T.5
-
16
-
-
47049127942
-
Gallbladder cancer
-
Gourgiotis, S.; Kocher, H.M.; Solaini, L.; Yarollahi, A.; Tsiambas, E.; Salemis, N.S. Gallbladder cancer. Am J Surg 2008, 196, 252-264.
-
(2008)
Am J Surg
, vol.196
, pp. 252-264
-
-
Gourgiotis, S.1
Kocher, H.M.2
Solaini, L.3
Yarollahi, A.4
Tsiambas, E.5
Salemis, N.S.6
-
17
-
-
58149529709
-
Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer
-
Adachi, Y.; Takeuchi, T.; Nagayama, T.; Ohtsuki, Y.; Furihata, M. Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 2009, 583, 430-436.
-
(2009)
FEBS Lett
, vol.583
, pp. 430-436
-
-
Adachi, Y.1
Takeuchi, T.2
Nagayama, T.3
Ohtsuki, Y.4
Furihata, M.5
-
18
-
-
3042658493
-
AMEKinhibitor ( U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: Analysis in a novel orthotopic inoculation model
-
Horiuchi, H.; Kawamata, H.; Fujimori, T.; Kuroda, Y. AMEKinhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model. Int J Oncol 2003, 23, 957-963.
-
(2003)
Int J Oncol
, Issue.23
, pp. 957-963
-
-
Horiuchi, H.1
Kawamata, H.2
Fujimori, T.3
Kuroda, Y.4
-
19
-
-
18044378377
-
Oncolytic adenoviral therapy in gallbladder carcinoma
-
Tekant, Y.; Davydova, J.; Ramirez, P.J.; Curiel, D.T.; Vickers, S.M.; Yamamoto, M. Oncolytic adenoviral therapy in gallbladder carcinoma. Surgery 2005, 137, 527-535.
-
(2005)
Surgery
, vol.137
, pp. 527-535
-
-
Tekant, Y.1
Davydova, J.2
Ramirez, P.J.3
Curiel, D.T.4
Vickers, S.M.5
Yamamoto, M.6
-
20
-
-
0009482260
-
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
-
Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76, 4350-4354.
-
(1979)
Proc Natl Acad Sci USA
, vol.76
, pp. 4350-4354
-
-
Towbin, H.1
Staehelin, T.2
Gordon, J.3
-
21
-
-
0031570938
-
Transgenic expression of a novel thymic epithelial cell antigen stimulates abberant development of thymocytes
-
Takeuchi, T.; Kuro-o, M.; Miyazawa, H.; Ohtsuki, Y.; Yamamoto, H. Transgenic expression of a novel thymic epithelial cell antigen stimulates abberant development of thymocytes. J Immunol 1997, 159, 726-733.
-
(1997)
J Immunol
, vol.159
, pp. 726-733
-
-
Takeuchi, T.1
Kuro-O, M.2
Miyazawa, H.3
Ohtsuki, Y.4
Yamamoto, H.5
-
22
-
-
2442689399
-
Serine/ threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance
-
Tanno, S.; Yanagawa, N.; Habiro, A.; Koizumi, K.; Nakano, Y.; Osanai, M.; Mizukami, Y.; Okumura, T.; Testa, J.R.; Kohgo, Y. Serine/ threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance. Cancer Res 2004, 64, 3486-3490.
-
(2004)
Cancer Res
, vol.64
, pp. 3486-3490
-
-
Tanno, S.1
Yanagawa, N.2
Habiro, A.3
Koizumi, K.4
Nakano, Y.5
Osanai, M.6
Mizukami, Y.7
Okumura, T.8
Testa, J.R.9
Kohgo, Y.10
-
23
-
-
0029804116
-
Mechanism of activation of protein kinase B by insulin and IGF-1
-
Alessi, D.R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P.; Hemmings, B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO Journal 1996, 15, 6541-6551.
-
(1996)
EMBO Journal
, vol.15
, pp. 6541-6551
-
-
Alessi, D.R.1
Andjelkovic, M.2
Caudwell, B.3
Cron, P.4
Morrice, N.5
Cohen, P.6
Hemmings, B.A.7
-
24
-
-
9244247669
-
Regulation of p53 activity through lysine methylation
-
Chuikov, S.; Kurash, J.K.; Wilson, J.R.; Xian, B.; Justin, N.; Ivanov, G.S.; McKinney, K.; Tempst, P.; Prives, C.; Gamblin, S.J.; Barlev, N.A.; Reinberg, D. Regulation of p53 activity through lysine methylation. Nature 2004, 432, 353-360.
-
(2004)
Nature
, vol.432
, pp. 353-360
-
-
Chuikov, S.1
Kurash, J.K.2
Wilson, J.R.3
Xian, B.4
Justin, N.5
Ivanov, G.S.6
McKinney, K.7
Tempst, P.8
Prives, C.9
Gamblin, S.J.10
Barlev, N.A.11
Reinberg, D.12
-
25
-
-
0028389376
-
Mutation of the p53 gene in gallbladder cancer
-
Takagi, S.; Naito, E.; Yamanouchi, H.; Ohtsuka, H.; Kominami, R.; Yamamoto, M. Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med 1994, 172, 283-289.
-
(1994)
Tohoku J Exp Med
, vol.172
, pp. 283-289
-
-
Takagi, S.1
Naito, E.2
Yamanouchi, H.3
Ohtsuka, H.4
Kominami, R.5
Yamamoto, M.6
-
26
-
-
0028334592
-
Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions
-
Wee, A.; Teh, M.; Raju, G.C. Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol 1994, 47, 453-456.
-
(1994)
J Clin Pathol
, vol.47
, pp. 453-456
-
-
Wee, A.1
Teh, M.2
Raju, G.C.3
-
27
-
-
0028982217
-
P53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival
-
Diamantis, I.; Karamitopoulou, E.; Perentes, E.; Zimmermann, A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995, 22, 774-779.
-
(1995)
Hepatology
, vol.22
, pp. 774-779
-
-
Diamantis, I.1
Karamitopoulou, E.2
Perentes, E.3
Zimmermann, A.4
-
28
-
-
0032752063
-
Cellular survival: A play in three akts
-
Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: a play in three akts. Gene Dev 1999, 13, 2905-2927.
-
(1999)
Gene Dev
, vol.13
, pp. 2905-2927
-
-
Datta, S.R.1
Brunet, A.2
Greenberg, M.E.3
-
29
-
-
1542781732
-
Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B
-
Bae, S.S.; Cho, H.; Mu, J.; Birnbaum, M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 2003, 278, 49530-49536.
-
(2003)
J Biol Chem
, vol.278
, pp. 49530-49536
-
-
Bae, S.S.1
Cho, H.2
Mu, J.3
Birnbaum, M.J.4
-
30
-
-
0033618371
-
Up-regulation of Akt3 in estrogen receptordeficient breast cancers and androgen-independent prostate cancer lines
-
Nakatani, K.; Thompson, D.A.; Barthel, A.; Sakaue, H.; Liu, W.; Weigel,R.J.; Roth, R.A. Up-regulation of Akt3 in estrogen receptordeficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 1999, 274, 21528-21532.
-
(1999)
J Biol Chem
, vol.274
, pp. 21528-21532
-
-
Nakatani, K.1
Thompson, D.A.2
Barthel, A.3
Sakaue, H.4
Liu, W.5
Weigel, R.J.6
Roth, R.A.7
-
31
-
-
4944249733
-
Deregulated Akt3 activity promotes development of malignant melanoma
-
Stahl, J.M.; Sharma, A.; Cheung, M.; Zimmerman, M.; Cheng, J.Q.; Bosenberg, M.W.; Kester, M.; Sandirasegarane, L.; Robertson, G.P. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 2004, 64, 7002-7010.
-
(2004)
Cancer Res
, vol.64
, pp. 7002-7010
-
-
Stahl, J.M.1
Sharma, A.2
Cheung, M.3
Zimmerman, M.4
Cheng, J.Q.5
Bosenberg, M.W.6
Kester, M.7
Sandirasegarane, L.8
Robertson, G.P.9
-
32
-
-
33846252336
-
A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition
-
Cristiano, B.E.; Chan, J.C.; Hannan, K.M.; Lundie, N.A.; Marmy- Conus, N.J.; Campbell, I.G.; Phillips, W.A.; Robbie, M.; Hannan, R.D.; Pearson, R.B. A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. Cancer Res 2006, 66, 11718-11725.
-
(2006)
Cancer Res
, vol.66
, pp. 11718-11725
-
-
Cristiano, B.E.1
Chan, J.C.2
Hannan, K.M.3
Lundie, N.A.4
Marmy- Conus, N.J.5
Campbell, I.G.6
Phillips, W.A.7
Robbie, M.8
Hannan, R.D.9
Pearson, R.B.10
-
33
-
-
7944235758
-
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
-
Jacinto, E.; Loewith, R.; Schmidt, A.; Lin, S.; Ruegg, M.A.; Hall, A.; Hall, M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6, 1122-1128.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 1122-1128
-
-
Jacinto, E.1
Loewith, R.2
Schmidt, A.3
Lin, S.4
Ruegg, M.A.5
Hall, A.6
Hall, M.N.7
-
34
-
-
0036258163
-
Apoptosislinked gene 2-deficient mice exhibit normal T-cell development and function
-
Jang, I.K.; Hu, R.; Lacana, E.; D'Adamio, L.; Gu, H. Apoptosislinked gene 2-deficient mice exhibit normal T-cell development and function. Mol Cell Biol 2002, 22, 4094-4100.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 4094-4100
-
-
Jang, I.K.1
Hu, R.2
Lacana, E.3
D'Adamio, L.4
Gu, H.5
-
35
-
-
0037020680
-
2+-binding modulator protein involved in cell proliferation and in cell death
-
2+-binding modulator protein involved in cell proliferation and in cell death. Biochim Biophys Acta 2002, 1600, 68-73.
-
(2002)
Biochim Biophys Acta
, vol.1600
, pp. 68-73
-
-
Krebs, J.1
Saremaslani, P.2
Caduff, R.3
-
36
-
-
0038307187
-
Up-regulation of ALG-2 in hepatomas and lung cancer tissue
-
la Cour, J.M.; Mollerup, J.; Winding, P.; Tarabykina, S.; Sehested, M.; Berchtold, M.W. Up-regulation of ALG-2 in hepatomas and lung cancer tissue. Am J Pathol 2003, 163, 81-89.
-
(2003)
Am J Pathol
, vol.163
, pp. 81-89
-
-
La Cour, J.M.1
Mollerup, J.2
Winding, P.3
Tarabykina, S.4
Sehested, M.5
Berchtold, M.W.6
-
37
-
-
48249094201
-
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features
-
Aviel-Ronen, S.; Coe, B.P.; Lau, S.K.; da Cunha Santos, G.; Zhu, C.Q.; Strumpf, D.; Jurisica, I.; Lam, W.L.; Tsao, M.S. Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci USA 2008, 105, 10155-10160.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 10155-10160
-
-
Aviel-Ronen, S.1
Coe, B.P.2
Lau, S.K.3
Da Cunha Santos, G.4
Zhu, C.Q.5
Strumpf, D.6
Jurisica, I.7
Lam, W.L.8
Tsao, M.S.9
-
38
-
-
35148895851
-
SND1 a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis
-
Tsuchiya, N.; Ochiai, M.; Nakashima, K.; Ubagai, T.; Sugimura, T.; Nakagama, H. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res 2007, 67, 9568-9576.
-
(2007)
Cancer Res
, vol.67
, pp. 9568-9576
-
-
Tsuchiya, N.1
Ochiai, M.2
Nakashima, K.3
Ubagai, T.4
Sugimura, T.5
Nakagama, H.6
|